These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12652627)

  • 21. [Treatment of myelodysplastic syndromes with immunosuppressive agents].
    Tohyama K; Ishikawa T
    Rinsho Ketsueki; 2002 Apr; 43(4):261-4. PubMed ID: 12043204
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful cyclosporine therapy for a young patient with refractory anemia, myelodysplastic syndrome].
    Tajima E; Mihara M; Wakabayashi M; Watarai M; Sugamura K; Miyashita M; Imamura A; Miwa H; Kato Y; Nitta M
    Nihon Naika Gakkai Zasshi; 2001 Jun; 90(6):1070-2. PubMed ID: 11460371
    [No Abstract]   [Full Text] [Related]  

  • 24. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.
    Al-Abdwani RM; Khamis FA; Balkhair A; Sacharia M; Wali YA
    Pediatr Hematol Oncol; 2008 Sep; 25(7):699-703. PubMed ID: 18850484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin.
    Pardos-Gea J; Ordi-Ros J; Altisent C; Balada E; Pérez-López J; Vilardell M
    Thromb Haemost; 2006 Apr; 95(4):735-7. PubMed ID: 16601847
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppressive therapy for patients with refractory anemia.
    Asano Y; Maeda M; Uchida N; Yokoyama T; Osaki K; Shimoda K; Gondo H; Okamura T; Okamura S; Niho Y
    Ann Hematol; 2001 Nov; 80(11):634-8. PubMed ID: 11757721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)].
    Murase K; Matsunaga T; Takimoto R; Takahira N; Fujimi A; Takeuchi N; Terui T; Niitsu Y
    Rinsho Ketsueki; 2004 May; 45(5):383-6. PubMed ID: 15199747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunosuppressive therapy of refractory anemia--clinical trials of cyclosporin A therapy in Japan].
    Tohyama K; Ishikawa T
    Rinsho Ketsueki; 2005 May; 46(5):324-9. PubMed ID: 16444965
    [No Abstract]   [Full Text] [Related]  

  • 31. [Curative effects of cyclosporin A therapy upon myelodysplastic syndrome].
    Chen SC; Jiang B; Da WM; Gong M; Guan M
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2711-5. PubMed ID: 17199984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive therapy for myelodysplastic syndromes: refining the indications.
    Barrett AJ; Sloand EM
    Curr Hematol Malig Rep; 2008 Jan; 3(1):23-8. PubMed ID: 20425443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome.
    Saunthararajah Y; Nakamura R; Wesley R; Wang QJ; Barrett AJ
    Blood; 2003 Oct; 102(8):3025-7. PubMed ID: 12829603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
    Fang JP; Xu HG; Huang SL; Chen C; Huang K
    Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelodysplastic syndrome.
    Nakao S; Deeg HJ; Ishikawa T; Marsh J; List A; Tomonaga M
    Int J Hematol; 2005 Dec; 82(5):412-6. PubMed ID: 16533744
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of myelodysplastic syndromes.
    Stadler M; Ganser A
    N Engl J Med; 2005 May; 352(20):2134-5; author reply 2134-5. PubMed ID: 15906434
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of adult patients with aplastic anemia in Japan].
    Urabe A; Ichiki S; Usukine K; Ijima K
    Rinsho Ketsueki; 2005 Jun; 46(6):389-93. PubMed ID: 16447719
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99).
    Hasegawa D; Manabe A; Yagasaki H; Ohtsuka Y; Inoue M; Kikuchi A; Ohara A; Tsuchida M; Kojima S; Nakahata T;
    Pediatr Blood Cancer; 2009 Dec; 53(6):1011-5. PubMed ID: 19499580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
    Biesma DH; van den Tweel JG; Verdonck LF
    Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
    Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR
    Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.